ATOS NASDAQ
Atossa Therapeutics, Inc.
1W: +23.2%
1M: -4.9%
3M: +2.6%
YTD: -75.3%
1Y: -83.0%
3Y: -79.7%
5Y: -95.4%
$2.34
+0.07 (+3.08%)
Weekly Expected Move ±12.2%
$2
$2
$2
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2024-11-19
Earliest Filing
2026-02-20
Latest Filing
partner: 3
Counterparties (Filed by ATOS)
3 relationshipsCompanies named in ATOS's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Rodman & Renshaw LLC | — | partner | Sales Agent for At the Market Offering Agreement | 2026-02-20 | View |
| Jefferies LLC | JEF | partner | Counterparty to terminated Open Market Sale Agreement | 2026-02-20 | View |
| Jefferies LLC | JEF | partner | Sales agent for the Open Market Sale Agreement | 2024-11-19 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-29 | Other Events; Exhibits | View | |
| 2026-09-18 | Regulation FD; Exhibits | View | |
| 2026-08-07 | Earnings Release; Exhibits | View | |
| 2026-06-11 | Material Agreement; Exhibits | Agreement | View |
| 2026-05-08 | Shareholder Vote | View | |
| 2026-05-08 | Exhibits | View | |
| 2026-04-16 | Other Events | View | |
| 2026-03-25 | Exhibits | View | |
| 2026-02-20 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Financial St | Agreement | View |
| 2026-02-17 | Notice of Delisting or Transfer | View | |
| 2026-02-11 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-01-26 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2026-01-09 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-01-06 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-04 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-14 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure | View | |
| 2025-09-26 | Regulation FD Disclosure | View | |
| 2025-09-08 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-21 | Notice of Delisting or Transfer | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR